| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 4.97 Billion | USD 7.72 Billion | 4.5% | 2024 |
FrequentlyAsked Questions
The Global contrast media/contrast agent market is expected to grow due to rising demand for early disease diagnosis, increasing prevalence of chronic diseases requiring diagnostic imaging, advancements in medical imaging technologies and minimally invasive procedures, and a growing number of hospitals and diagnostic centers worldwide.
According to a study, the Global contrast media/contrast agent market size was worth around USD 4.97 Billion in 2024 and is expected to reach USD 7.72 Billion by 2034.
The Global contrast media/contrast agent market is expected to grow at a CAGR of 4.5% during the forecast period.
North America is expected to dominate the contrast media/contrast agent market over the forecast period.
Leading players in the Global contrast media/contrast agent market include Bracco Imaging Spa, CMC Contrast AB, GE Healthcare, Guerbet Group, Nanopet Pharma GmbH., Sanochemia Pharmazeutika AG, Subhra Pharma Private, Ltd., Covidien, Daiichi Sankyo Co., Ltd., Genovis AB, Lantheus Medical Imaging, Inc., Nanoscan Imaging, LLC., Spago Imaging AB, Taejoon Pharm Co., Ltd., among others.
The report explores crucial aspects of the contrast media/contrast agent market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients